Table 3.
Blood analysis of participants according to spirometry FEV1/FVC <0.70
| COPD (n=33) | Non-COPD (n=100) | Total (n=133) | P-value | |
|---|---|---|---|---|
| Total cholesterol (mg/dL) | 161.33 (46.29) | 182.86 (42.92) | 177.24 (44.64) | 0.02 |
| HDL cholesterol (mg/dL) | 45.46 (12.97) | 45.98 (11.98) | 45.85 (12.182) | ns |
| LDL cholesterol (mg/dL) | 90 (32.59) | 106.35 (39.78) | 102.41 (38.66) | ns |
| Triglycerides (mg/dL) | 105.69 (92.46) | 134.29 (73.26) | 127.02 (79.14) | ns |
| CRP | 2 (5.45) | 0.87 (2.1) | 1.13 (3.21) | ns |
| BNP (pg/mL) | 1,839 (4,137) | 832 (2,437) | 1,092 (2,984) | ns |
| Total cholesterola (mg/dL) | 167 (40.37) | 181 (43.95) | 177 (43.2) | ns |
| HDL cholesterola (mg/dL) | 46.24 (11.25) | 44.68 (11.65) | 45.1 (11.5) | ns |
| LDL cholesterola (mg/dL) | 96.82 (31.8) | 102.9 (41.2) | 101.49 (38.99) | ns |
Note:
a
Total cholesterol levels and fractions in patients with previously prescribed statins. Data are presented as mean (standard deviation).
Abbreviations: COPD, chronic obstructive pulmonary disease; FEV1, forced expiratory volume in the 1st second; FVC, forced vital capacity. BNP, brain natriuretic peptide; CRP, c-reactive protein; HDL, high density lipoprotein; LDL, low density lipoprotein; ns, non-significant.